Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Convertible Preferred Stock and Changes in Stockholders??? Equity (Deficit)

v3.21.1
Consolidated Statements of Convertible Preferred Stock and Changes in Stockholders’ Equity (Deficit) - USD ($)
Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Balance at Dec. 31, 2018 $ 38,257,039 $ 83 $ 2,773,470 $ (49,775,915) $ (48,303) $ (47,050,665)
Balance (in Shares) at Dec. 31, 2018 8,050,502 829,938        
Conversion of bridge loan to Series B convertible preferred stock $ 2,609,321
Conversion of bridge loan to Series B convertible preferred stock (in Shares) 1,281,631        
Beneficial conversion feature related to convertible notes payable $ 1,078,769
Issuance of Series B convertible preferred stock, net of issuance costs $ 11,937,331
Issuance of Series B convertible preferred stock, net of issuance costs (in Shares) 5,306,910        
Repurchase of common stock
Repurchase of common stock (in Shares) (346)        
Exercise of common stock options 3,533 3,533
Exercise of common stock options (in Shares) 3,913        
Stock-based compensation expense 397,099 397,099
Foreign currency translation adjustment 6,903 6,903
Net loss (18,498,341) (18,498,341)
Balance at Dec. 31, 2019 $ 53,882,460 $ 83 3,174,102 (68,274,256) (41,400) (65,141,471)
Balance (in Shares) at Dec. 31, 2019 14,639,043 833,505        
Issuance of Series B convertible preferred stock, net of issuance costs $ 400,504
Issuance of Series B convertible preferred stock, net of issuance costs (in Shares) 173,752        
Conversion of convertible preferred stock to common stock $ (54,242,464) $ 1,480 54,240,984 54,242,464
Conversion of convertible preferred stock to common stock (in Shares) (14,804,274) 14,804,274        
Reclassification of convertible preferred stock warrant liability 5,230,687 5,230,687
Payment to unaccredited investors upon consummation of the Merger $ (40,500) $ (18) (546,183)     (546,201)
Payment to unaccredited investors upon consummation of the Merger (in Shares) (8,521) (183,510)        
Issuance of common stock to former stockholders of Malo Holdings Corporation   $ 217 (52,261)     (52,044)
Issuance of common stock to former stockholders of Malo Holdings Corporation (in Shares)   2,166,667        
Sale of common stock in private placement $ 914 24,255,180 24,256,094
Sale of common stock in private placement (in Shares) 9,138,855        
Exercise of common stock options $ 10 80,477 80,487
Exercise of common stock options (in Shares) 100,059        
Stock-based compensation expense 668,072 668,072
Foreign currency translation adjustment (10,762) (10,762)
Net loss (15,603,716) (15,603,716)
Balance at Dec. 31, 2020 $ 2,686 $ 87,051,058 $ (83,877,972) $ (52,162) $ 3,123,610
Balance (in Shares) at Dec. 31, 2020 26,859,850